NDC 50090-2153-00 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-2153
- Requested NDC
- 50090-2153-00
- Package NDCs from labels
- 50090-2153-0, 50090-2153-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - A-S Medication Solutions | A-S Medication Solutions | 2024-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-2153-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | 43 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-2153 | DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS] | 43 | Current NDC, Legacy NDC, 1 package rows | 20241025_4034fb6d-f55d-4df0-b500-d6a413591f6e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2153-0 | EA - Each | 50090-2153 | 421ab72c-a8c9-411c-bd3b-767009381793 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN MESYLATE | Aurobindo Pharma Limited | 93f2d724-5a54-4721-b04a-e46bc764607b | 2024-09-06 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 8c0c0345-833b-4a3d-9081-da66b208d750 | 2024-09-05 | Warnings, Adverse reactions | ANDA202824 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ef8b5534-5939-400a-ad5e-f9ceaefc4097 | 2024-09-05 | Warnings, Adverse reactions | ANDA202824 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ac4cd22b-2a03-47b6-9eed-550be278f17d | 2024-09-05 | Warnings, Adverse reactions | ANDA202824 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Accord Healthcare Inc. | 2830533c-ccdf-4401-b19c-763eeb1bc0a7 | 2024-08-15 | Warnings, Adverse reactions | ANDA202824 16729-213 16729-211 197625 197628 197626 197627 1fbdaa94-b68a-b934-e063-6294a90a8b77 2830533c-ccdf-4401-b19c-763eeb1bc0a7 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 40e47e75-6a47-323b-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | ANDA202824 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Rising Pharma Holdings, Inc. | 508b908e-8d80-422e-8ec0-2081185f4c95 | 2024-06-19 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 4034fb6d-f55d-4df0-b500-d6a413591f6e | 2024-06-12 | Warnings, Adverse reactions | ANDA202824 50090-2153-0 50090-2172-0 50090-2172-1 50090-2154-0 50090-2418-0 50090-2172-2 50090-2154-1 50090-2153 50090-2172 50090-2418 50090-2154 50090215300 197625 197628 197626 197627 e184efc2-7240-4202-9778-f8d9d1fdf9ca 4034fb6d-f55d-4df0-b500-d6a413591f6e 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 9f67fa58-f623-4145-9e2c-98feee7ca45f | 2024-06-10 | Warnings, Adverse reactions | ANDA202824 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a243e6-7056-115d-e053-2a91aa0a510f | 2024-06-06 | Warnings, Adverse reactions | ANDA202824 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a19cb1-79fc-8b0b-e053-2a91aa0aaa94 | 2024-06-06 | Warnings, Adverse reactions | ANDA202824 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 1d8ff659-8129-4dca-9e8f-13b97240d1e1 | 2024-06-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 187bc51b-7a3a-5910-e063-6294a90aa888 | 2024-05-15 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f | 2024-04-29 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 368GB5141J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.